Accredo
HIPAA |  Terms of use |  Medco |  Contact us
   
Patients Healthcare professionals Health plans & payor clients Manufacturers Careers About Accredo
 
 
 

Patients

Getting started with Accredo
Our services
Search drug therapies
Therapy management
Nexavar® (sorafenib) - overview

Nexavar® (sorafenib)

Overview | Product information | Accredo services | Contact team


Several different types of cancer can develop in the kidney. Conventional or clear cell renal cell cancer, also known as renal cell carcinoma, is by far the most common type of kidney cancer in adults. Renal cell carcinoma accounts for about 85 percent of cancers arising from the kidney.1 Renal cell carcinoma develops in the tubules of the kidney, part of the filtering system. It is characterized by a lack of early warning signs, diverse clinical manifestations, and resistance to radiation and chemotherapy.

Referral Form

Other Resources:

National Cancer Institute

Nexavar.com


1. Cancer FAQs about kidney cancer. National Foundation for Cancer Research.


Nexavar is a registered trademark of Bayer Pharmaceuticals Corporation.

 
 
 

Quick links

Search Search drug therapies
Doctor Referral Doctor referral forms
Patient Authorization Patient authorization form
Contact Us Contact us